Published in Microbiol Rev on June 01, 1980
Comparison of initiation of protein synthesis in procaryotes, eucaryotes, and organelles. Microbiol Rev (1983) 24.58
A segment of the 5' nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation. J Virol (1988) 13.93
Summary: the modified nucleosides of RNA. Nucleic Acids Res (1994) 9.76
Bidirectional RNA helicase activity of eucaryotic translation initiation factors 4A and 4F. Mol Cell Biol (1990) 7.33
Mechanism and regulation of eukaryotic protein synthesis. Microbiol Rev (1992) 6.27
The roles of individual eukaryotic translation initiation factors in ribosomal scanning and initiation codon selection. Genes Dev (2002) 4.96
In vivo transcriptional pausing and cap formation on three Drosophila heat shock genes. Proc Natl Acad Sci U S A (1993) 4.82
Mutations in translation initiation factors lead to increased rates of deadenylation and decapping of mRNAs in Saccharomyces cerevisiae. Mol Cell Biol (1999) 4.35
Transcription and replication of rhabdoviruses. Microbiol Rev (1987) 4.05
Cap-dependent and cap-independent translation by internal initiation of mRNAs in cell extracts prepared from Saccharomyces cerevisiae. Mol Cell Biol (1994) 3.76
Structure of the sucrose synthase gene on chromosome 9 of Zea mays L. EMBO J (1985) 3.62
Evidence that a capped oligoribonucleotide is the primer for duck hepatitis B virus plus-strand DNA synthesis. J Virol (1986) 3.46
Proteolysis of the p220 component of the cap-binding protein complex is not sufficient for complete inhibition of host cell protein synthesis after poliovirus infection. J Virol (1987) 3.07
mRNA decapping in yeast requires dissociation of the cap binding protein, eukaryotic translation initiation factor 4E. Mol Cell Biol (2000) 3.06
Alternative translation of human fibroblast growth factor 2 mRNA occurs by internal entry of ribosomes. Mol Cell Biol (1995) 3.02
Initiation and termination of duck hepatitis B virus DNA synthesis during virus maturation. J Virol (1987) 2.89
Gene and genon concept: coding versus regulation. A conceptual and information-theoretic analysis of genetic storage and expression in the light of modern molecular biology. Theory Biosci (2007) 2.89
Multiple injections of electroporated autologous T cells expressing a chimeric antigen receptor mediate regression of human disseminated tumor. Cancer Res (2010) 2.64
Translational control of viral gene expression in eukaryotes. Microbiol Mol Biol Rev (2000) 2.63
Amino acid sequence of the mRNA cap-binding protein from human tissues. Proc Natl Acad Sci U S A (1987) 2.61
Cationic liposome-mediated RNA transfection. Proc Natl Acad Sci U S A (1989) 2.55
Induction of sporulation in Saccharomyces cerevisiae leads to the formation of N6-methyladenosine in mRNA: a potential mechanism for the activity of the IME4 gene. Nucleic Acids Res (2002) 2.51
Processing of genome 5' termini as a strategy of negative-strand RNA viruses to avoid RIG-I-dependent interferon induction. PLoS One (2008) 2.45
Gamma-monomethyl phosphate: a cap structure in spliceosomal U6 small nuclear RNA. Proc Natl Acad Sci U S A (1989) 2.34
Trypanosome mRNAs have unusual "cap 4" structures acquired by addition of a spliced leader. Proc Natl Acad Sci U S A (1987) 2.31
Expression of a cDNA encoding a functional 241-kilodalton vesicular stomatitis virus RNA polymerase. Proc Natl Acad Sci U S A (1985) 2.28
The effect of capping and polyadenylation on the stability, movement and translation of synthetic messenger RNAs in Xenopus oocytes. Nucleic Acids Res (1985) 2.28
Inhibition of host translation in encephalomyocarditis virus-infected L cells: a novel mechanism. J Virol (1982) 2.13
Temporal order of RNA-processing reactions in trypanosomes: rapid trans splicing precedes polyadenylation of newly synthesized tubulin transcripts. Mol Cell Biol (1993) 2.12
The 5' ends of Hantaan virus (Bunyaviridae) RNAs suggest a prime-and-realign mechanism for the initiation of RNA synthesis. J Virol (1995) 2.10
Precise localization of m6A in Rous sarcoma virus RNA reveals clustering of methylation sites: implications for RNA processing. Mol Cell Biol (1985) 2.06
Erythroid cell-specific mRNA stability elements in the alpha 2-globin 3' nontranslated region. Mol Cell Biol (1995) 2.04
Effects of cDNA hybridization on translation of encephalomyocarditis virus RNA. J Virol (1987) 2.02
A novel mechanism for the initiation of Tacaribe arenavirus genome replication. J Virol (1990) 1.98
Mature mRNAs of Trypanosoma brucei possess a 5' cap acquired by discontinuous RNA synthesis. Nucleic Acids Res (1985) 1.97
Regulation of eukaryotic gene expression by the untranslated gene regions and other non-coding elements. Cell Mol Life Sci (2012) 1.96
Photochemical cross-linking of cap binding proteins to eucaryotic mRNAs: effect of mRNA 5' secondary structure. Mol Cell Biol (1985) 1.93
Synthesis of adeno-associated virus structural proteins requires both alternative mRNA splicing and alternative initiations from a single transcript. J Virol (1988) 1.89
Specificity of RNA maturation pathways: RNAs transcribed by RNA polymerase III are not substrates for splicing or polyadenylation. Mol Cell Biol (1987) 1.83
Yeast mRNA cap methyltransferase is a 50-kilodalton protein encoded by an essential gene. Mol Cell Biol (1995) 1.82
Scanning independent ribosomal initiation of the Sendai virus X protein. EMBO J (1988) 1.77
Capped and conserved terminal structures in human rotavirus genome double-stranded RNA segments. J Virol (1983) 1.75
Direct analysis of the mini-exon donor RNA of Trypanosoma brucei: detection of a novel cap structure also present in messenger RNA. Nucleic Acids Res (1987) 1.72
Beta-globin mRNAs capped with m7G, m2.7(2)G or m2.2.7(3)G differ in intrinsic translation efficiency. Nucleic Acids Res (1988) 1.72
Modification of ribosomal RNA by ribosome-inactivating proteins from plants. Nucleic Acids Res (1988) 1.70
An efficient strategy to isolate full-length cDNAs based on an mRNA cap retention procedure (CAPture). Mol Cell Biol (1995) 1.70
Translational repression by a complex between the iron-responsive element of ferritin mRNA and its specific cytoplasmic binding protein is position-dependent in vivo. EMBO J (1990) 1.70
Tacaribe arenavirus RNA synthesis in vitro is primer dependent and suggests an unusual model for the initiation of genome replication. J Virol (1992) 1.63
Transcript initiation and 5'-end modifications are separable events during vesicular stomatitis virus transcription. J Virol (1999) 1.61
Identification of the DNA sequences encoding the large subunit of the mRNA-capping enzyme of vaccinia virus. J Virol (1984) 1.60
Characterization of the genomic promoter of the prototypic arenavirus lymphocytic choriomeningitis virus. J Virol (2003) 1.56
Translational control of ribosomal protein synthesis during early Dictyostelium discoideum development. Mol Cell Biol (1987) 1.51
Translation and processing of mouse hepatitis virus virion RNA in a cell-free system. J Virol (1986) 1.51
Isolation and structural characterization of cap-binding proteins from poliovirus-infected HeLa cells. J Virol (1985) 1.51
Molecular biology: The long and short of RNAs. Nature (2009) 1.51
Identification of nuclear cap specific proteins in HeLa cells. Nucleic Acids Res (1987) 1.50
RNA polymerase of vesicular stomatitis virus specifically associates with translation elongation factor-1 alphabetagamma for its activity. Proc Natl Acad Sci U S A (1998) 1.49
Cap-specific mRNA (nucleoside-O2'-)-methyltransferase and poly(A) polymerase stimulatory activities of vaccinia virus are mediated by a single protein. Proc Natl Acad Sci U S A (1992) 1.46
DcpS can act in the 5'-3' mRNA decay pathway in addition to the 3'-5' pathway. Proc Natl Acad Sci U S A (2003) 1.44
Altered mRNA cap recognition activity of initiation factor 4E in the yeast cell cycle division mutant cdc33. Nucleic Acids Res (1989) 1.43
Both the 5' untranslated region and the sequences surrounding the start site contribute to efficient initiation of translation in vitro. Mol Cell Biol (1991) 1.42
Biochemical characterisation of cap-poly(A) synergy in rabbit reticulocyte lysates: the eIF4G-PABP interaction increases the functional affinity of eIF4E for the capped mRNA 5'-end. Nucleic Acids Res (2000) 1.42
Mutations in the 5' NTR and the Non-Structural Protein 3A of the Coxsackievirus B3 Selectively Attenuate Myocarditogenicity. PLoS One (2015) 1.39
Identification of promoter-proximal oligonucleotides and a unique dinucleotide, pppGpC, from in vitro transcription products of vesicular stomatitis virus. J Virol (1981) 1.38
Presence of the cap-binding protein in initiation factor preparations from poliovirus-infected HeLa cells. J Virol (1981) 1.35
Mutational analysis of the Saccharomyces cerevisiae ABD1 gene: cap methyltransferase activity is essential for cell growth. Mol Cell Biol (1996) 1.32
Capped mRNAs with reduced secondary structure can function in extracts from poliovirus-infected cells. Mol Cell Biol (1982) 1.32
Assembly of pre-mRNA splicing complex is cap dependent. Nucleic Acids Res (1987) 1.30
Enzymology of RNA cap synthesis. Wiley Interdiscip Rev RNA (2010) 1.30
Expression of mRNA electroporated into plant and animal cells. Nucleic Acids Res (1987) 1.27
Host range mutants of vesicular stomatitis virus defective in in vitro RNA methylation. Proc Natl Acad Sci U S A (1982) 1.26
Evidence for translational regulation of herpes simplex virus type 1 gD expression. J Virol (1984) 1.24
Restricted replication of human hepatitis A virus in cell culture: intracellular biochemical studies. J Virol (1981) 1.23
Modifications of the 5' cap of mRNAs during Xenopus oocyte maturation: independence from changes in poly(A) length and impact on translation. Mol Cell Biol (1998) 1.23
Expression and characterization of an RNA capping enzyme encoded by Chlorella virus PBCV-1. J Virol (1996) 1.22
Histidine-mediated RNA transfer to GDP for unique mRNA capping by vesicular stomatitis virus RNA polymerase. Proc Natl Acad Sci U S A (2010) 1.19
Polyadenylated, noncapped RNA from the archaebacterium Methanococcus vannielii. J Bacteriol (1985) 1.19
Capping of mammalian U6 small nuclear RNA in vitro is directed by a conserved stem-loop and AUAUAC sequence: conversion of a noncapped RNA into a capped RNA. Mol Cell Biol (1990) 1.19
Preferential translation of vesicular stomatitis virus mRNAs is conferred by transcription from the viral genome. J Virol (2006) 1.18
Reaction mechanism of mRNA guanylyltransferase from rat liver: isolation and characterization of a guanylyl-enzyme intermediate. Proc Natl Acad Sci U S A (1982) 1.17
Heterogeneity of the 5' terminus of hen ovalbumin messenger ribonucleic acid. Nucleic Acids Res (1981) 1.15
Efficient transcription, not translation, is dependent on adenovirus tripartite leader sequences at late times of infection. J Virol (1988) 1.15
Capping and methylation of mRNA by purified recombinant VP4 protein of bluetongue virus. Proc Natl Acad Sci U S A (1998) 1.14
Reassignment of specificities of two cap methyltransferase domains in the reovirus lambda 2 protein. Genome Biol (2001) 1.12
B2 RNA and 7SK RNA, RNA polymerase III transcripts, have a cap-like structure at their 5' end. Nucleic Acids Res (1990) 1.11
Where do introns come from? PLoS Biol (2008) 1.10
mRNA:guanine-N7 cap methyltransferases: identification of novel members of the family, evolutionary analysis, homology modeling, and analysis of sequence-structure-function relationships. BMC Bioinformatics (2001) 1.09
Translational control of the activation of transcription factor NF-κB and production of type I interferon by phosphorylation of the translation factor eIF4E. Nat Immunol (2012) 1.09
Transcription initiation by RNA polymerase II is inhibited by S-adenosylhomocysteine. Proc Natl Acad Sci U S A (1982) 1.07
The cap of both miniexon-derived RNA and mRNA of trypanosomes is 7-methylguanosine. Mol Cell Biol (1988) 1.07
Ifit1 inhibits Japanese encephalitis virus replication through binding to 5' capped 2'-O unmethylated RNA. J Virol (2013) 1.07
Biochemical and structural insights into the mechanisms of SARS coronavirus RNA ribose 2'-O-methylation by nsp16/nsp10 protein complex. PLoS Pathog (2011) 1.05
Doing it in reverse: 3'-to-5' polymerization by the Thg1 superfamily. RNA (2012) 1.05
Covalent guanylyl intermediate formed by HeLa cell mRNA capping enzyme. Mol Cell Biol (1982) 1.04
Developing mRNA-vaccine technologies. RNA Biol (2012) 1.04
Effect of phosphorylated ribavirin on vesicular stomatitis virus transcription. Antimicrob Agents Chemother (1988) 1.03
Formation of guanosine(5')tetraphospho(5')adenosine cap structure by an unconventional mRNA capping enzyme of vesicular stomatitis virus. J Virol (2008) 1.02
Disruption of largest subunit RNA polymerase II genes in Trypanosoma brucei. Mol Cell Biol (1993) 1.00
Complete cap 4 formation is not required for viability in Trypanosoma brucei. Eukaryot Cell (2006) 1.00
Trimethylguanosine capping selectively promotes expression of Rev-dependent HIV-1 RNAs. Proc Natl Acad Sci U S A (2010) 0.99
How do eucaryotic ribosomes select initiation regions in messenger RNA? Cell (1978) 12.04
Capping of eucaryotic mRNAs. Cell (1976) 10.84
Coincidence of the promoter and capped 5' terminus of RNA from the adenovirus 2 major late transcription unit. Cell (1978) 9.60
A protein covalently linked to poliovirus genome RNA. Proc Natl Acad Sci U S A (1977) 7.92
Heterogeneity and 5'-terminal structures of the late RNAs of simian virus 40. J Mol Biol (1978) 7.64
5'-terminal structure of poliovirus polyribosomal RNA is pUp. Proc Natl Acad Sci U S A (1976) 6.78
End labeling of enzymatically decapped mRNA. Nucleic Acids Res (1977) 6.58
Reovirus messenger RNA contains a methylated, blocked 5'-terminal structure: m-7G(5')ppp(5')G-MpCp-. Proc Natl Acad Sci U S A (1975) 6.26
5'-Terminal structure and mRNA stability. Nature (1977) 5.32
Methylated nucleotides block 5'-terminus of vaccinia virus messenger RNA. Proc Natl Acad Sci U S A (1975) 5.16
Methylation-dependent translation of viral messenger RNAs in vitro. Proc Natl Acad Sci U S A (1975) 5.02
Inhibition of translation by poliovirus: inactivation of a specific initiation factor. Proc Natl Acad Sci U S A (1978) 4.59
5'-Terminal 7-methylguanosine in eukaryotic mRNA is required for translation. Nature (1975) 4.45
A polypeptide in eukaryotic initiation factors that crosslinks specifically to the 5'-terminal cap in mRNA. Proc Natl Acad Sci U S A (1978) 4.45
The 5' terminal structure of the methylated mRNA synthesized in vitro by vesicular stomatitis virus. Cell (1975) 4.43
Globin mRNAs are primers for the transcription of influenza viral RNA in vitro. Proc Natl Acad Sci U S A (1978) 4.17
Efficient translation of prokaryotic mRNAs in a eukaryotic cell-free system requires addition of a cap structure. Nature (1979) 4.11
Identification of methylated nucleosides in messenger RNA from Novikoff hepatoma cells. Proc Natl Acad Sci U S A (1974) 3.94
RNA synthesis in isolated nuclei: in vitro initiation of adenovirus 2 major late mRNA precursor. Proc Natl Acad Sci U S A (1979) 3.75
Methylation of newly synthesized viral messenger RNA by an enzyme in vaccinia virus. Proc Natl Acad Sci U S A (1974) 3.68
Purification of mRNA guanylyltransferase and mRNA (guanine-7-) methyltransferase from vaccinia virions. J Biol Chem (1975) 3.66
A blocked structure at the 5' terminus of mRNA from cytoplasmic polyhedrosis virus. Nature (1975) 3.59
Vesicular stomatitis virus: mode of transcription. J Gen Virol (1977) 3.53
Methylated nucleotides block 5' terminus of HeLa cell messenger RNA. Cell (1975) 3.46
Heterogneeous 5'-terminal structures occur on vesicular stomatitis virus mRNAs. J Biol Chem (1975) 3.44
Methylated messenger RNA synthesis in vitro by purified reovirus. Proc Natl Acad Sci U S A (1974) 3.44
Sequences containing methylated nucleotides at the 5' termini of messenger RNAs: possible implications for processing. Cell (1974) 3.39
Tandem promoters direct E. coli ribosomal RNA synthesis. Cell (1979) 3.36
"Methylation-coupled" transcription by virus-associated transcriptase of cytoplasmic polyhedrosis virus containing double-stranded RNA. Nucleic Acids Res (1974) 3.36
Are the 5' ends of influenza viral mRNAs synthesized in vivo donated by host mRNAs? Cell (1979) 3.35
Inhibition of the transition of a 40 S ribosome-Met-tRNA-i-Met complex to an 80 S ribosome-Met-tRNA-i-Met- complex by 7-Methylguanosine-5'-phosphate. Nature (1976) 3.26
The role of DNA in RNA synthesis, IX. Nucleoside triphosphate termini in RNA polymerase products. Proc Natl Acad Sci U S A (1965) 3.18
Inhibition of initiation of protein synthesis by 7-methylguanosine-5'-monophosphate. Proc Natl Acad Sci U S A (1976) 3.14
Transfer of 5'-terminal cap of globin mRNA to influenza viral complementary RNA during transcription in vitro. Proc Natl Acad Sci U S A (1979) 3.10
Methylated, blocked 5 termini in HeLa cell mRNA. Proc Natl Acad Sci U S A (1975) 3.02
5'-Terminal m-7G(5')ppp(5')G-m-p in vivo: identification in reovirus genome RNA. Proc Natl Acad Sci U S A (1975) 3.01
Modified nucleosides and bizarre 5'-termini in mouse myeloma mRNA. Nature (1975) 2.97
Acidic dissociation of 7:9-dialkylguanines and its possible relation to mutagenic properties of alkylating agents. Nature (1961) 2.94
Primary sequence of U-1 nuclear ribonucleic acid of Novikoff hepatoma ascites cells. J Biol Chem (1974) 2.90
Wheat embryo ribonucleates. XII. Formal characterization of terminal and penultimate nucleoside residues at the 5'-ends of "capped" RNA from imbibing wheat embryos. Can J Biochem (1978) 2.87
Migration of 40 S ribosomal subunits on messenger RNA in the presence of edeine. J Biol Chem (1978) 2.84
The methylated constituents of L cell messenger RNA: evidence for an unusual cluster at the 5' terminus. Cell (1975) 2.82
Eukaryotic mRNA cap binding protein: purification by affinity chromatography on sepharose-coupled m7GDP. Proc Natl Acad Sci U S A (1979) 2.81
Translation in vitro of vesicular stomatitis virus mRNA lacking 5'-terminal 7-methylguanosine. Nature (1976) 2.81
Methylated simian virus 40-specific RNA from nuclei and cytoplasm of infected BSC-1 cells. Proc Natl Acad Sci U S A (1975) 2.81
Ribosome binding to reovirus mRNA in protein synthesis requires 5' terminal 7-methylguanosine. Cell (1975) 2.78
Modification of RNA by mRNA guanylyltransferase and mRNA (guanine-7-)methyltransferase from vaccinia virions. J Biol Chem (1975) 2.76
5'-terminal sequence of vesicular stomatitis virus mRNA's synthesized in vitro. J Virol (1975) 2.73
Nucleotide sequences at the 5'termini of rabbit alpha and beta globin mRNA. Cell (1976) 2.73
5'-Terminal nucleotide sequences of the double-stranded RNA of silkworm cytoplasmic polyhedrosis virus. J Mol Biol (1974) 2.71
Blocked, methylated 5'-terminal sequence in avian sarcoma virus RNA. Nature (1975) 2.66
Mechanism of formation of reovirus mRNA 5'-terminal blocked and methylated sequence, m7GpppGmpC. J Biol Chem (1976) 2.60
Purification of a factor that restores translation of vesicular stomatitis virus mRNA in extracts from poliovirus-infected HeLa cells. Proc Natl Acad Sci U S A (1980) 2.46
Importance of 5'-terminal blocking structure to stabilize mRNA in eukaryotic protein synthesis. Proc Natl Acad Sci U S A (1977) 2.45
In vitro synthesis of methylated messenger RNA by the virion-associated RNA polymerase of vesicular stomatitis virus. Cell (1974) 2.42
Inability of circular mRNA to attach to eukaryotic ribosomes. Nature (1979) 2.42
Novel initiation of RNA synthesis in vitro by vesicular stomatitis virus. Nature (1975) 2.36
Protein covalently linked to foot-and-mouth disease virus RNA. Nature (1977) 2.35
Transcription units for mRNA production in eukaryotic cells and their DNA viruses. Prog Nucleic Acid Res Mol Biol (1979) 2.34
The addition of 5' cap structures occurs early in hnRNA synthesis and prematurely terminated molecules are capped. Cell (1980) 2.32
Control of protein synthesis in extracts from poliovirus-infected cells. I. mRNA discrimination by crude initiation factors. J Virol (1978) 2.31
Effects of some chemical mutagens and carcinogens on nucleic acids. Prog Nucleic Acid Res Mol Biol (1966) 2.31
5'-Terminal and internal methylated nucleotide sequences in HeLa cell mRNA. Biochemistry (1976) 2.28
A modified structure at the 5'-terminus of mRNA of vaccinia virus. FEBS Lett (1975) 2.23
Influenza viral mRNA contains internal N6-methyladenosine and 5'-terminal 7-methylguanosine in cap structures. J Virol (1976) 2.22
Multiple 5' terminal cap structures in late polyoma virus RNA. Cell (1979) 2.21
Methylated, blocked 5' termini of yeast mRNA. J Biol Chem (1976) 2.20
Kinetics of formation of 5' terminal caps in mRNA. Cell (1976) 2.16
Methylated and blocked 5' termini in vesicular stomatitis virus in vivo mRNAs. Cell (1975) 2.15
The 5' end group of tobacco mosaic virus RNA is m7G5' ppp5' Gp. Nucleic Acids Res (1975) 2.13
Methyl labeling of HeLa cell hnRNA: a comparison with mRNA. Cell (1976) 2.13
Modification of the 5'-terminus of mRNA by soluble guanylyl and methyl transferases from vaccinia virus. Proc Natl Acad Sci U S A (1975) 2.10
Evidence for role of m7G5'-phosphate group in recognition of eukaryotic mRNA by initiation factor IF-M3. Nature (1976) 2.09
The 5'-terminal nucleotide sequences of the double-stranded RNA of human reovirus. Proc Natl Acad Sci U S A (1974) 2.08
Identification of the 5' end of Rous sarcoma virus RNA. Proc Natl Acad Sci U S A (1975) 2.01
Influence of 5'-terminal m7G and 2'--O-methylated residues on messenger ribonucleic acid binding to ribosomes. Biochemistry (1976) 1.99
Characterization of Novikoff hepatoma mRNA methylation and heterogeneity in the methylated 5' terminus. Biochemistry (1975) 1.96
Cap and internal nucleotides of reovirus mRNA primers are incorporated into influenza viral complementary RNA during transcription in vitro. J Virol (1979) 1.95
mRNA guanylyltransferase and mRNA (guanine-7-)-methyltransferase from vaccinia virions. Donor and acceptor substrate specificites. J Biol Chem (1976) 1.95
Sequence of methylated nucleotides at the 5'-terminus of adenovirus-specific RNA. J Virol (1976) 1.94
Nucleotide sequence of turnip yellow mosaic virus coat protein mRNA. Cell (1978) 1.91
Comparison of methylated sequences in messenger RNA and heterogeneous nuclear RNA from mouse L cells. J Mol Biol (1977) 1.90
A novel phosphodiesterase from cultured tobacco cells. Biochemistry (1976) 1.90
The genome-linked protein of picornaviruses. IV. Difference in the VPg's of encephalomyocarditis virus and poliovirus as evidence that the genome-linked proteins are virus-coded. Virology (1978) 1.89
Purification of mRNA guanylyltransferase from vaccinia virions. J Biol Chem (1978) 1.89
Sequence heterogeneity at the 5' termini of late simian virus 40 19S and 16S mRNAs. Proc Natl Acad Sci U S A (1979) 1.88
Relative importance of 7-methylguanosine in ribosome binding and translation of vesicular stomatitis virus mRNA in wheat germ and reticulocyte cell-free systems. J Biol Chem (1977) 1.85
Effect of 5'-terminal structure and base composition on polyribonucleotide binding to ribosomes. J Mol Biol (1976) 1.84
Localization of the 5' terminus of late SV40 mRNA. Nucleic Acids Res (1978) 1.80
Giant heterogeneous polyadenylic acid on vesicular stomatitis virus mRNA synthesized in vitro in the presence of S-adenosylhomocysteine. J Virol (1977) 1.80
Modification of the 5' terminus of mRNA by an RNA (guanine-7-)-methyltransferase from HeLa cells. J Biol Chem (1976) 1.80
Sequence specificity of internal methylation in B77 avian sarcoma virus RNA subunits. Biochemistry (1977) 1.80
A protein linked to the 5' termini of both RNA components of the cowpea mosaic virus genome. Nucleic Acids Res (1978) 1.79
Translational discrimination of 'capped' and 'non-capped' mRNAS: inhibition of a series of chemical analogs of m7GpppX. FEBS Lett (1976) 1.77
Localization of N6-methyladenosine in the Rous sarcoma virus genome. J Mol Biol (1977) 1.77
5'-Terminal capping of RNA by guanylyltransferase from HeLa cell nuclei. Proc Natl Acad Sci U S A (1977) 1.77
Nucleotide sequences at the N6-methyladenosine sites of HeLa cell messenger ribonucleic acid. Biochemistry (1977) 1.76
Identification and mapping of N6-methyladenosine containing sequences in simian virus 40 RNA. Nucleic Acids Res (1979) 1.75
Alterations in initiation factor activity from poliovirus-infected HeLa cells. J Biol Chem (1979) 1.75
Synthesis and chemical properties of monomers and polymers containing 7-methylguanine and an investigation of their substrate or template properties for bacterial deoxyribonucleic acid or ribonucleic acid polymerases. Biochemistry (1970) 1.74
Sequential transcription of the genes of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1976) 5.88
Methylation-dependent translation of viral messenger RNAs in vitro. Proc Natl Acad Sci U S A (1975) 5.02
Exclusion of elderly people from clinical research: a descriptive study of published reports. BMJ (1997) 4.95
The 5' terminal structure of the methylated mRNA synthesized in vitro by vesicular stomatitis virus. Cell (1975) 4.43
Translation and identification of the mRNA species synthesized in vitro by the virion-associated RNA polymerase of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1975) 4.17
Transcription and replication of rhabdoviruses. Microbiol Rev (1987) 4.05
A unique RNA species involved in initiation of vesicular stomatitis virus RNA transcription in vitro. Cell (1976) 3.82
Oxygen desaturation during endoscopy in the elderly. J R Coll Physicians Lond (1993) 3.37
In vitro synthesis of RNA that contains polyadenylate by virion-associated RNA polymerase of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1973) 3.17
Transcription in vitro by reovirus-associated ribonucleic acid-dependent polymerase. J Virol (1970) 3.07
Complete nucleotide sequence of the leader RNA synthesized in vitro by vesicular stomatitis virus. Cell (1978) 3.06
Messenger RNA species synthesized in vitro by the virion-associated RNA polymerase of vesicular stomatitis virus. Cell (1975) 3.04
Studies on the in vitro adenylation of RNA by vesicular stomatitis virus. Virology (1974) 2.83
5'-terminal sequence of vesicular stomatitis virus mRNA's synthesized in vitro. J Virol (1975) 2.73
Translation and identification of the viral mRNA species isolated from subcellular fractions of vesicular stomatitis virus-infected cells. J Virol (1975) 2.68
In vitro synthesis of methylated messenger RNA by the virion-associated RNA polymerase of vesicular stomatitis virus. Cell (1974) 2.42
Unique mode of transcription in vitro by Vesicular stomatitis virus. Cell (1980) 2.36
Novel initiation of RNA synthesis in vitro by vesicular stomatitis virus. Nature (1975) 2.36
Rescue of synthetic analogs of genome RNA of human parainfluenza virus type 3. Virology (1993) 2.33
An infectious clone of human parainfluenza virus type 3. J Virol (1997) 2.28
Improving cancer radiotherapy with 2-deoxy-D-glucose: phase I/II clinical trials on human cerebral gliomas. Int J Radiat Oncol Biol Phys (1996) 2.15
Methylated and blocked 5' termini in vesicular stomatitis virus in vivo mRNAs. Cell (1975) 2.15
Phosphorylation by cellular casein kinase II is essential for transcriptional activity of vesicular stomatitis virus phosphoprotein P. Proc Natl Acad Sci U S A (1992) 2.03
Influence of 5'-terminal m7G and 2'--O-methylated residues on messenger ribonucleic acid binding to ribosomes. Biochemistry (1976) 1.99
Phosphorylation within a specific domain of the phosphoprotein of vesicular stomatitis virus regulates transcription in vitro. Cell (1987) 1.92
Intervening polyadenylate sequences in RNA transcripts of vesicular stomatitis virus. Cell (1978) 1.92
Sub-cellular localization of vesicular stomatitis virus messenger RNAs. Biochem Biophys Res Commun (1975) 1.91
Complex formation with vesicular stomatitis virus phosphoprotein NS prevents binding of nucleocapsid protein N to nonspecific RNA. J Virol (1988) 1.91
Sequential phosphorylation of the phosphoprotein of vesicular stomatitis virus by cellular and viral protein kinases is essential for transcription activation. J Virol (1992) 1.88
Identification of a domain within the phosphoprotein of vesicular stomatitis virus that is essential for transcription in vitro. Proc Natl Acad Sci U S A (1986) 1.87
Requirements and functions of vesicular stomatitis virus L and NS proteins in the transcription process in vitro. Biochem Biophys Res Commun (1985) 1.79
Parasitic infections of the lung: a guide for the respiratory physician. Thorax (2010) 1.78
Mapping and initiation studies on the leader RNA of vesicular stomatitis virus. Virology (1977) 1.78
Vesicular stomatitis virus NS proteins: structural similarity without extensive sequence homology. J Virol (1985) 1.73
Transcriptional activity and mutational analysis of recombinant vesicular stomatitis virus RNA polymerase. J Virol (1993) 1.73
Mapping of interacting domains between the nucleocapsid protein and the phosphoprotein of vesicular stomatitis virus by using a two-hybrid system. Proc Natl Acad Sci U S A (1993) 1.63
Initiation of reovirus mRNA synthesis in vitro. Nat New Biol (1971) 1.61
Cloning and expression of the vesicular stomatitis virus phosphoprotein gene in Escherichia coli: analysis of phosphorylation status versus transcriptional activity. J Virol (1991) 1.60
Simultaneous pulmonary and cerebral oedema, and multiple CNS infarctions as complications of diabetic ketoacidosis: a case report. Diabet Med (2006) 1.60
The nature of the RNA products synthesized in vitro by subviral components of visicular stomatitis virus. Virology (1976) 1.60
Resolution of multiple complexes of phosphoprotein NS with nucleocapsid protein N of vesicular stomatitis virus. J Virol (1988) 1.57
Common variable immune deficiency: respiratory manifestations, pulmonary function and high-resolution CT scan findings. QJM (2002) 1.54
In vitro synthesis of messenger RNA by a defective interfering particle of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1977) 1.51
Endoscopic transthoracic sympathectomy in the treatment of hyperhidrosis. Ann Surg (1992) 1.51
Does a doctor's dress-style matter? Med J Aust (1988) 1.49
RNA polymerase of vesicular stomatitis virus specifically associates with translation elongation factor-1 alphabetagamma for its activity. Proc Natl Acad Sci U S A (1998) 1.49
Complications of parotid surgery: the need for selectivity. Br J Surg (1989) 1.48
In vitro phosphorylation of NS protein by the L protein of vesicular stomatitis virus. J Gen Virol (1985) 1.48
RNA editing in the phosphoprotein gene of the human parainfluenza virus type 3. Virology (1992) 1.44
In vitro RNA transcription by the New Jersey serotype of vesicular stomatitis virus. I. Characterization of the mRNA species. J Virol (1978) 1.44
Initiation of RNA synthesis in vitro by vesicular stomatitis virus. Role of ATP. J Biol Chem (1979) 1.43
Replication of RNA viruses. X. Replication of a natural 6 s RNA by the Q-beta RNA polymerase. J Mol Biol (1969) 1.42
Two methyltransferase activities in the purified virions of vesicular stomatitis virus. J Virol (1977) 1.42
Guanosine-5'-diphosphate at the 5' termini of reovirus RNA: evidence for a segmented genome within the virion. J Mol Biol (1971) 1.40
Anterior tibial artery embolectomy augmented by dynamic on-table angiography. Lancet (1991) 1.39
Specific interactions of vesicular stomatitis virus L and NS proteins with heterologous genome ribonucleoprotein template lead to mRNA synthesis in vitro. J Virol (1984) 1.39
Phosphorylation of specific serine residues within the acidic domain of the phosphoprotein of vesicular stomatitis virus regulates transcription in vitro. J Virol (1992) 1.38
Communication in surgical practice. J R Soc Med (1987) 1.38
The life and work of the Birmingham radiologist Dr James Brailsford (1888-1961). J Med Biogr (2004) 1.38
Identification of promoter-proximal oligonucleotides and a unique dinucleotide, pppGpC, from in vitro transcription products of vesicular stomatitis virus. J Virol (1981) 1.38
Intramedullary spinal cysticercosis. Case report and review of literature. Clin Neurol Neurosurg (1987) 1.38
Purified matrix protein of vesicular stomatitis virus blocks viral transcription in vitro. Proc Natl Acad Sci U S A (1982) 1.34
Cellular protein kinase C isoform zeta regulates human parainfluenza virus type 3 replication. Proc Natl Acad Sci U S A (1995) 1.33
Phosphorylation within the amino-terminal acidic domain I of the phosphoprotein of vesicular stomatitis virus is required for transcription but not for replication. J Virol (1997) 1.31
Characterization of the in vitro system for the synthesis of mRNA from human respiratory syncytial virus. Virology (1993) 1.31
The transcription complex of vesicular stomatitis virus. Cell (1987) 1.30
High prevalence of subclinical hypothyroidism during first trimester of pregnancy in North India. Indian J Endocrinol Metab (2013) 1.30
Association of simple anthropometric measures of obesity with visceral fat and the metabolic syndrome in male Caucasian and Indo-Asian subjects. Diabet Med (2004) 1.30
Phosphoprotein NS of vesicular stomatitis virus: phosphorylated states and transcriptional activities of intracellular and virion forms. Virology (1986) 1.29
Specific interaction in vitro and in vivo of glyceraldehyde-3-phosphate dehydrogenase and LA protein with cis-acting RNAs of human parainfluenza virus type 3. J Biol Chem (1996) 1.29
Crohn's or poisoning? Gut (1988) 1.29
In vitro synthesis of the full-length complement of the negative-strand genome RNA of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1980) 1.28
Absence of abdominal pain in elderly patients with peptic ulcer. Age Ageing (1984) 1.27
In vivo methylation of vesicular stomatitis virus and its host-cell messenger RNA species. Virology (1976) 1.27
Messenger RNA encoding the phosphoprotein (P) gene of human parainfluenza virus 3 is bicistronic. Virology (1986) 1.26
Precise mapping of the replication and transcription promoters of human parainfluenza virus type 3. Virology (2000) 1.26
Cytosine at the 3'-termini of reovirus genome and in vitro mRNA. Nat New Biol (1971) 1.25
Studies on the in vivo and in vitro messenger RNA species of vesicular stomatitis virus. Virology (1975) 1.23
Non-steroidal anti-inflammatory drugs and peptic ulceration. J R Coll Physicians Lond (1987) 1.23
Sequences of Chandipura virus N and NS genes: evidence for high mutability of the NS gene within vesiculoviruses. Virology (1987) 1.22
Role of cellular actin in human parainfluenza virus type 3 genome transcription. J Biol Chem (1993) 1.22
NH2-terminal acidic region of the phosphoprotein of vesicular stomatitis virus can be functionally replaced by tubulin. Proc Natl Acad Sci U S A (1988) 1.21
Involvement of actin microfilaments in the replication of human parainfluenza virus type 3. J Virol (1998) 1.21
Percutaneous needle biopsies of renal allografts: the relationship between morphological changes present in biopsies and subsequent allograft function. Histopathology (1977) 1.20
Human parainfluenza virus type 3 transcription in vitro: role of cellular actin in mRNA synthesis. J Virol (1991) 1.20
Characterization of an in vitro system for the synthesis of mRNA from human parainfluenza virus type 3. J Virol (1990) 1.19
Involvement of cellular casein kinase II in the phosphorylation of measles virus P protein: identification of phosphorylation sites. Virology (1995) 1.18
Nucleotide sequence of the leader RNA of the New Jersey serotype of vesicular stomatitis virus. Nucleic Acids Res (1978) 1.18
Seasonal distribution of Vibrio parahaemolyticus in freshwater environs and in association with freshwater fishes in Calcutta. Appl Environ Microbiol (1985) 1.18
Patterns of urine flow and electrolyte excretion in healthy elderly people. Br Med J (Clin Res Ed) (1983) 1.18
Absence of polyadenylic acid from reovirus messenger ribonucleic acid. J Biol Chem (1973) 1.14
The functional domains of the phosphoprotein (NS) of vesicular stomatitis virus (Indiana serotype). Virology (1988) 1.14
Characterization of vesicular stomatitis virus mRNA species synthesized in vitro. J Virol (1977) 1.14
Role of cellular casein kinase II in the function of the phosphoprotein (P) subunit of RNA polymerase of vesicular stomatitis virus. J Biol Chem (1995) 1.12
Inhibition of human parainfluenza virus-3 replication by interferon and human MxA. Virology (1996) 1.12
Structure and expression of the glycoprotein gene of Chandipura virus. Virology (1989) 1.12
Replication of RNA viruses. V. Template activity of synthetic ribopolymers in the Q-beta RNA polymerase reaction. Proc Natl Acad Sci U S A (1967) 1.11
Polarity of human parainfluenza virus type 3 infection in polarized human lung epithelial A549 cells: role of microfilament and microtubule. J Virol (2001) 1.09